Total planned funding: $330,481,511
Clear active filters
FHI 360
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Nigeria | $80,704,508 |
Mozambique | $66,854,973 |
Zambia | $57,012,884 |
South Africa | $23,072,289 |
Kenya | $13,002,332 |
Vietnam | $11,889,164 |
India | $8,637,057 |
Papua New Guinea | $5,486,330 |
Tanzania | $5,450,000 |
Indonesia | $5,126,794 |
Côte d'Ivoire | $5,005,736 |
Burundi | $4,608,504 |
Botswana | $4,510,003 |
Zimbabwe | $4,344,201 |
Democratic Republic of the Congo | $3,890,975 |
Asia Regional Program | $3,400,093 |
Eswatini | $2,867,187 |
Malawi | $2,801,446 |
Ghana | $2,750,000 |
Haiti | $2,616,452 |
Caribbean Region | $2,525,420 |
Angola | $2,466,719 |
South Sudan | $2,266,962 |
Ethiopia | $2,222,911 |
Cambodia | $2,025,000 |
Uganda | $1,795,686 |
Rwanda | $1,687,592 |
Namibia | $1,210,293 |
Dominican Republic | $250,000 |
Central Asia Region | $0 |
Organizational Types
NGO | $330,481,511 |
Program Areas
Treatment | $99,305,772 |
Care | $90,495,442 |
Prevention | $84,764,140 |
Governance and Systems | $27,981,318 |
Testing | $27,934,839 |
Budget Codes
HTXS: Treatment: Adult Treatment | $85,831,719 |
HKID: Care: Orphans and Vulnerable Children | $42,459,666 |
HVOP: Sexual Prevention: Other Sexual Prevention | $39,582,596 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $33,810,597 |
HBHC: Care: Adult Care and Support | $32,521,629 |
HVCT: Testing: HIV Testing and Counseling | $27,934,839 |
PDTX: Treatment: Pediatric Treatment | $13,474,053 |
OHSS: Health Systems Strengthening | $10,853,361 |
HLAB: Laboratory Infrastructure | $8,788,767 |
HVSI: Strategic Information | $8,339,190 |
PDCS: Care: Pediatric Care and Support | $8,163,615 |
HVTB: Care: TB/HIV | $7,350,532 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $4,504,710 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $3,418,590 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $2,768,404 |
HMBL: Biomedical Prevention: Blood Safety | $361,526 |
HMIN: Biomedical Prevention: Injection Safety | $317,717 |
HTXD: Treatment: ARV Drugs | $0 |